Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis.

Hanna Pohjantähti-Maaroos, Ari Palomäki, Juha Hartikainen
Author Information
  1. Hanna Pohjantähti-Maaroos: Department of Emergency Medicine, Kanta-Häme Central Hospital, Hämeenlinna, Finland. hanna.pohjantahti-maaroos@kuh.fi

Abstract

BACKGROUND: Erectile dysfunction (ED), impaired arterial elasticity, elevated resting heart rate as well as increased levels of oxidized LDL and fibrinogen associate with future cardiovascular events. Physical activity is crucial in the prevention of cardiovascular diseases (CVD), while metabolic syndrome (MetS) comprises an increased risk for CVD events. The aim of this study was to assess whether markers of subclinical atherosclerosis are associated with the presence of ED and MetS, and whether physical activity is protective of ED.
METHODS: 57 MetS (51.3 ± 8.0 years) and 48 physically active (PhA) (51.1 ± 8.1 years) subjects participated in the study. ED was assessed by the International Index of Erectile Function (IIEF) questionnaire, arterial elasticity by a radial artery tonometer (HDI/PulseWave™ CR-2000) and circulating oxLDL by a capture ELISA immunoassay. Fibrinogen and lipids were assessed by validated methods. The calculation of mean daily energy expenditure of physical exercise was based on a structured questionnaire.
RESULTS: ED was more often present among MetS compared to PhA subjects, 63.2% and 27.1%, respectively (p < 0.001). Regular physical exercise at the level of > 400 kcal/day was protective of ED (OR 0.12, 95% CI 0.017-0.778, p = 0.027), whereas increased fibrinogen (OR 4.67, 95% CI 1.171-18.627, p = 0.029) and elevated resting heart rate (OR 1.07, 95% CI 1.003-1.138, p = 0.04) were independently associated with the presence of ED. In addition, large arterial elasticity (ml/mmHgx10) was lower among MetS compared to PhA subjects (16.6 ± 4.0 vs. 19.6 ± 4.2, p < 0.001), as well as among ED compared to non-ED subjects (16.7 ± 4.6 vs. 19.0 ± 3.9, p = 0.008). Fibrinogen and resting heart rate were highest and large arterial elasticity lowest among subjects with both MetS and ED.
CONCLUSIONS: Markers of subclinical atherosclerosis associated with the presence of ED and were most evident among subjects with both MetS and ED. Thus, especially MetS patients presenting with ED should be considered at high risk for CVD events. Physical activity, on its part, seems to be protective of ED.
TRIAL REGISTRATION: ClinicalTrials.gov NCT01119404.

Associated Data

ClinicalTrials.gov | NCT01119404

References

  1. JAMA. 2005 Dec 21;294(23):2996-3002 [PMID: 16414947]
  2. J Sex Med. 2011 Jul;8(7):1903-16 [PMID: 21569211]
  3. Eur Urol. 2007 Dec;52(6):1590-600 [PMID: 17707576]
  4. JAMA. 2005 Oct 12;294(14):1799-809 [PMID: 16219884]
  5. Hypertension. 1995 Sep;26(3):503-8 [PMID: 7649589]
  6. J Urol. 2006 Jul;176(1):217-21 [PMID: 16753404]
  7. Int J Clin Pract. 2011 Mar;65(3):274-80 [PMID: 21314864]
  8. Int J Clin Pract. 2005 Feb;59(2):225-9 [PMID: 15854201]
  9. Am J Hypertens. 2004 Apr;17(4):285-91 [PMID: 15062880]
  10. Urology. 1997 Jun;49(6):822-30 [PMID: 9187685]
  11. Am J Hypertens. 2005 Jan;18(1):65-71 [PMID: 15691619]
  12. Physiol Rev. 2004 Oct;84(4):1381-478 [PMID: 15383655]
  13. J Sex Med. 2008 Jun;5(6):1317-24 [PMID: 18194181]
  14. Metab Syndr Relat Disord. 2009 Dec;7(6):529-36 [PMID: 19900152]
  15. Circulation. 2002 Dec 17;106(25):3143-421 [PMID: 12485966]
  16. JAMA. 2004 Jun 23;291(24):2978-84 [PMID: 15213209]
  17. Mayo Clin Proc. 2009 Feb;84(2):108-13 [PMID: 19181643]
  18. Atherosclerosis. 2003 Jun;168(2):351-8 [PMID: 12801619]
  19. Eur Urol. 2009 Feb;55(2):509-16 [PMID: 18359146]
  20. Arterioscler Thromb Vasc Biol. 2001 May;21(5):844-8 [PMID: 11348884]
  21. Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504 [PMID: 10993420]
  22. Can J Cardiol. 2008 May;24 Suppl A:3A-8A [PMID: 18437251]
  23. Eur J Cardiovasc Prev Rehabil. 2005 Apr;12(2):144-50 [PMID: 15785300]
  24. Int J Clin Pract. 2010 Jun;64(7):848-57 [PMID: 20584218]
  25. Int J Obes Relat Metab Disord. 2002 Jun;26(6):805-13 [PMID: 12037651]
  26. Am J Hypertens. 2008 Feb;21(2):143-7 [PMID: 18188165]
  27. Arch Intern Med. 2004 May 24;164(10):1066-76 [PMID: 15159263]
  28. Cardiovasc Diabetol. 2010 Aug 20;9:41 [PMID: 20727144]
  29. Arch Gerontol Geriatr. 2007;44 Suppl 1:339-42 [PMID: 17317472]
  30. Stroke. 2001 Feb;32(2):454-60 [PMID: 11157182]
  31. Hypertens Res. 2004 Dec;27(12):897-901 [PMID: 15894828]
  32. J Am Coll Cardiol. 2010 Jan 26;55(4):350-6 [PMID: 20117441]
  33. J Gen Intern Med. 2005 Jun;20(6):515-9 [PMID: 15987326]
  34. Blood Press Suppl. 2003 Dec;2:29-34 [PMID: 14761074]
  35. Urology. 2008 Apr;71(4):703-7 [PMID: 18387399]
  36. Int J Androl. 2009 Dec;32(6):587-98 [PMID: 19226407]
  37. Blood Press Monit. 2002 Aug;7(4):231-5 [PMID: 12198339]
  38. Int J Cardiol. 2005 Aug 3;103(1):19-26 [PMID: 16061118]
  39. Am J Cardiol. 2005 Dec 26;96(12B):19M-23M [PMID: 16387561]
  40. Hypertension. 2002 Jan;39(1):10-5 [PMID: 11799071]
  41. JAMA. 2002 Jul 17;288(3):351-7 [PMID: 12117400]
  42. J Hypertens. 2008 Sep;26(9):1829-36 [PMID: 18698219]
  43. Urology. 1999 Aug;54(2):346-51 [PMID: 10443736]
  44. J Sports Med Phys Fitness. 2010 Mar;50(1):93-8 [PMID: 20308979]
  45. J Hypertens. 2010 Apr;28(4):687-94 [PMID: 20051904]
  46. Am J Hypertens. 2000 Dec;13(12):1243-9 [PMID: 11130766]
  47. Am Heart J. 2010 Apr;159(4):612-619.e3 [PMID: 20362720]
  48. J Epidemiol Community Health. 2012 May;66(5):427-32 [PMID: 21051780]
  49. Atherosclerosis. 2008 Jun;198(2):419-25 [PMID: 17977548]
  50. Eur Heart J. 2006 Nov;27(22):2640-8 [PMID: 17056702]
  51. Atherosclerosis. 2003 Apr;167(2):327-34 [PMID: 12818416]
  52. J Hypertens. 2007 May;25(5):909-20 [PMID: 17414649]
  53. Urology. 2007 Sep;70(3):558-62 [PMID: 17688916]
  54. Circulation. 2004 Nov 2;110(18):2858-63 [PMID: 15492301]
  55. Urology. 2007 Feb;69(2):356-60 [PMID: 17275074]
  56. Am J Med. 2007 Feb;120(2):151-7 [PMID: 17275456]
  57. J Am Coll Cardiol. 2004 Jan 21;43(2):179-84 [PMID: 14736434]

MeSH Term

Adult
Atherosclerosis
Biomarkers
Cross-Sectional Studies
Erectile Dysfunction
Heart Rate
Humans
Lipoproteins, LDL
Male
Metabolic Syndrome
Middle Aged
Motor Activity
Risk Factors
Surveys and Questionnaires
Vasodilation

Chemicals

Biomarkers
Lipoproteins, LDL
oxidized low density lipoprotein

Word Cloud

Created with Highcharts 10.0.0ED0MetS±subjectsp1amongarterialelasticityactivityphysical=4ErectilerestingheartrateincreasedeventsCVDatherosclerosisassociatedpresenceprotectivePhAcomparedOR95%CI6dysfunctionelevatedwellfibrinogencardiovascularPhysicalmetabolicriskstudywhethermarkerssubclinical5138yearsassessedquestionnaireFibrinogenexercise<001large16vs19BACKGROUND:impairedlevelsoxidizedLDLassociatefuturecrucialpreventiondiseasessyndromecomprisesaimassessMETHODS:5748physicallyactiveparticipatedInternationalIndexFunctionIIEFradialarterytonometerHDI/PulseWave™CR-2000circulatingoxLDLcaptureELISAimmunoassaylipidsvalidatedmethodscalculationmeandailyenergyexpenditurebasedstructuredRESULTS:oftenpresent632%271%respectivelyRegularlevel>400kcal/day12017-0778027whereas67171-1862702907003-113804independentlyadditionml/mmHgx10lower2non-ED79008highestlowestCONCLUSIONS:MarkersevidentThusespeciallypatientspresentingconsideredhighpartseemsTRIALREGISTRATION:ClinicalTrialsgovNCT01119404syndrome:differences

Similar Articles

Cited By